Cost to evidence
Which ventures reach credible external evidence before a conventional team or formation round would have been required?
For capital partners
Parallel Human is testing where machine intelligence changes the cost, timing, and purpose of early capital. Capital conversations are open now. No fund, allocation, or LP commitment process is open.
The question
Report 001 does not show that startups need less capital. It shows why the question is worth testing. Product judgment, founder runway, trusted access, customer acquisition, distribution, compliance, data, hardware, and scale can remain expensive after software exists.
Which ventures reach credible external evidence before a conventional team or formation round would have been required?
Where does later, milestone-based capital improve the decision rather than simply accelerate output?
Which ventures have earned dedicated capital, and which remain experiments, public goods, services, or closed work?
What is real
What is not established
Useful relationships now
Test the definitions, comparisons, missing evidence, and capital assumptions in Report 001.
Help PH find people whose work could test the model beyond Founder 0.
Talk about capital only where customer evidence, category needs, and a clear use of funds justify it.
Follow reports and corrections before deciding whether a future PH structure deserves deeper support.
Start here
The existing study-conversation path is manually reviewed. State what you are evaluating, what evidence would change your view, and where you think PH may be wrong.
This is not an open calendar, securities offer, allocation request, or LP commitment process.